We tested the hypothesis that chronic treatment with the direct renin inhibitor aliskiren improves vascular function in resistance and conduit arteries of type 2 diabetic and hypertensive patients. Sixteen patients with mild essential hypertension and with a previous diagnosis of non–insulindependent diabetes mellitus were included in the study. Patients were then randomized to aliskiren (150 mg once daily, n=9), or ramipril (5 mg once daily, n=7). Each patient underwent a biopsy of the subcutaneous tissue and small arteries were dissected and mounted on a pressurized micromyograph in order to evaluate endothelium dependent vasorelaxation in response to acetylcholine  L-NAME in vessels precontracted with norepinephrine. Endothelial function has been quantified also in large conduit arteries by Flow Mediated Dilation (FMD). A similar office blood pressure–lowering effect was observed with the 2 drugs, although changes in diastolic blood pressure were not statistically significant in the ramipril group. Aliskiren significantly improved endothelium-dependent relaxation in subcutaneous resistance arteries, as well as increased FMD in conduit arteries, whereas the effects induced by ramipril did not reach statistical significance. Only aliskiren significantly increased the expression of p1177-eNOS in the endothelium. Both aliskiren and ramipril had a negligible effect on markers of oxidative stress. Thus aliskiren restored endothelial function and induced a more prompt peripheral vasodilation in hypertensive and diabetic patients possibly through the increased production of NO via the enhanced expression and function of the active phosphorylated form of eNOS.

Effect of direct renin inhibition on vascular function after long-term treatment with aliskiren in hypertensive and diabetic patients

Carolina De Ciuceis;Anna Paini;Enrico Agabiti Rosei;Maria Lorenza Muiesan;Damiano Rizzoni;Massimo Salvetti.
2020-01-01

Abstract

We tested the hypothesis that chronic treatment with the direct renin inhibitor aliskiren improves vascular function in resistance and conduit arteries of type 2 diabetic and hypertensive patients. Sixteen patients with mild essential hypertension and with a previous diagnosis of non–insulindependent diabetes mellitus were included in the study. Patients were then randomized to aliskiren (150 mg once daily, n=9), or ramipril (5 mg once daily, n=7). Each patient underwent a biopsy of the subcutaneous tissue and small arteries were dissected and mounted on a pressurized micromyograph in order to evaluate endothelium dependent vasorelaxation in response to acetylcholine  L-NAME in vessels precontracted with norepinephrine. Endothelial function has been quantified also in large conduit arteries by Flow Mediated Dilation (FMD). A similar office blood pressure–lowering effect was observed with the 2 drugs, although changes in diastolic blood pressure were not statistically significant in the ramipril group. Aliskiren significantly improved endothelium-dependent relaxation in subcutaneous resistance arteries, as well as increased FMD in conduit arteries, whereas the effects induced by ramipril did not reach statistical significance. Only aliskiren significantly increased the expression of p1177-eNOS in the endothelium. Both aliskiren and ramipril had a negligible effect on markers of oxidative stress. Thus aliskiren restored endothelial function and induced a more prompt peripheral vasodilation in hypertensive and diabetic patients possibly through the increased production of NO via the enhanced expression and function of the active phosphorylated form of eNOS.
File in questo prodotto:
File Dimensione Formato  
2020 Aliskiren JH-D-20-00301_R1(1) con accettazione embedded.pdf

gestori archivio

Tipologia: Documento in Pre-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 2.43 MB
Formato Adobe PDF
2.43 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11379/531817
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
social impact